Catalent’s proprietary GPEx ® technology creates stable, high-yielding mammalian cell lines with high speed and efficiency, getting customer’s drug development projects to clinic in one-third the time ...
Biopharmaceutical products in development continue to increase in complexity, which poses a challenge for pharmaceutical companies looking to improve speed and efficiency of biologic development. Cell ...
Catalent, Inc. CTLT recently introduced GPEx Lightning, its next-generation cell line development technology. GPEx Lightning combines novel technologies, which include a gene insertion technology, to ...
Somerset, N.J. & Taizhou City, Zhejiang Province, China — Catalent Pharma Solutions, the leading global provider of development solutions and advanced delivery technologies for drug, biologic and ...
Catalent, Inc. CTLT recently introduced GPEx Lightning, its next-generation cell line development technology. GPEx Lightning combines novel technologies, which include a gene insertion technology, to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results